Pharmaceutical Excipient Market Overview and Outlook

Description

Inactive ingredients in drugs are gaining importance; excipients can improve process yield and decrease production risks, and offer competitive advantages over similar (or competing generic) medications with technologies like extended release or rapid release of the active pharmaceutical ingredient. The Pharmaceutical Excipient Market Overview and Outlook report offers readers the opportunity to gain insight into the biopharmaceutical excipient market and where it’s heading. Remaining aware of market dynamics and expected changes will enable readers to better make key decisions regarding excipient use and to help identify where competitive advantages may be gained.

Pharmaceutical Excipient Market Overview and Outlook

SPONSORS:

  • Learn more about how current trends are impacting drug developers’ use of excipients to gain competitive advantages with their drug products
  • Gather information on peers’ annual excipient expenditures, the proportion spent on proprietary excipients and a breakdown of expenditure by category (small molecule, generic, and biologic) and formulation (oral dose, sterile injectable, semi-solids and liquids, and specialty dosage forms)
  • Gain insight into excipient supplier selection criteria as well as the supplier characteristics that drive satisfaction

SERVICE PROVIDERS:

  • Understand how excipient usage trends will impact buying behavior
  • Gain insight into market growth factors and changes in demand for different categories of excipients
  • Learn which categories of excipients, and for which formulations drug developers are most likely to purchase proprietary excipients
  • Identify ways to better position your company to capture new business by understanding excipient supplier selection criteria and the decision-makers in choosing a provider
  • Market Dynamics
  • Service Provider Selection, Perceptions and Loyalty
  • Study Data

ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive

  • Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
  • Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries.  We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
  • Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.

For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.

Introduction

Methodology
How to Read this Report
Respondent Demographics and Qualifications
Respondent portfolio and pipeline drug product knowledge
Visibility into pipeline and portfolio of drug products

Market Dynamics

Primary Section Takeaways
Key objectives in excipient use
Department influence on excipient supplier selection
Excipient supplier resources and sources
Sponsor influence on excipient source

Sponsor perspective
CMO perspective

Small molecule originator drug products

Excipient use and proprietary excipient use by category
Proportion of proprietary excipients by category
Proprietary excipient use by formulation

Generic drug products

Excipient use and proprietary excipient use by category
Proprietary excipients use by category
Proprietary excipient use by formulation

Biologic drug products, including biosimilars

Excipient use and proprietary excipient use by category
Proportion of proprietary excipients by category
Proprietary excipient use by formulation

Annual excipient expenditure
Annual spend by company size
Proprietary vs non-proprietary excipient expenditure
Excipient market growth drivers

Service Provider Selection, Perceptions and Loyalty

Primary Section Takeaways
Top 5 excipient supplier selection attributes
Excipient supplier satisfaction drivers
Excipient suppliers
Use of preferred providers
Top suppliers by familiarity
Small molecule originator drugs

Excipient supplier consideration use, and loyalty

Generic small molecule drugs

Excipient supplier consideration use, and loyalty

Biologic drugs, including biosimilars

Excipient supplier consideration use, and loyalty

Study Data

Excipient Usage Objectives
Excipient supplier resources
Most useful excipient supplier resources
Excipient suppliers
Number of approved suppliers
Difficulty in using a non-preferred vendor
Excipient sources
Sponsor influence on excipient source—CMO perspective
Sponsor influence on excipient source—Sponsor perspective
Excipient categories for small molecule originator drug products
Use of proprietary excipients in originator small molecule drug products by formulation
Proprietary excipient categories for small molecule originator drug products
Percentage of proprietary excipients in small molecule drug products by category
Excipient categories for generic small molecule drug products
Use of proprietary excipients in generic small molecule drug products by formulation
Proprietary excipient categories for generic small molecule drug products
Percentage of proprietary excipients in generic small molecule drug products by category
Excipient categories for biologic drug products
Use of proprietary excipients in biologic drug products
Proprietary excipient categories for biologic drug products
Percentage of proprietary excipients in biologic drug products by category
Visibility and excipient expenditure
Proprietary vs non-proprietary excipient expenditure
Excipient expenditure by category and formulation
Excipient supplier selection attributes
Excipient supplier satisfaction drivers
Supplier familiarity
Excipient use by category
Excipient providers considered for small molecule originator drugs
Excipient use—small molecule originator drugs
Excipient supplier performance—small molecule originator drugs
Excipient supplier loyalty—small molecule originator drugs
Excipient providers considered for generic small molecule drugs
Excipient use—generic small molecule drugs
Excipient supplier performance—generic small molecule drugs
Excipient supplier loyalty—generic small molecule drugs
Excipient providers considered for biologic drugs
Excipient use—biologic drugs
Excipient supplier performance—biologic drugs
Excipient supplier loyalty—biologic drugs
Excipient market growth drivers
Department influence on excipient supplier selection

Demographics

Company size
Headquarters location
Office location
Job title
Decision-making responsibility—Sponsors
Decision-making responsibility—CMOs
Outsourcing influence
Formulation activities and excipient responsibilities—Sponsors
Excipient responsibilities—CMOs
Respondent portfolio and pipeline drug product knowledge
Visibility into pipeline and portfolio of drug products
Years of industry experience

Additional information

License

, ,